WellnessFX Consumer Health Open to Commerce and Expands on West Coast
SAN FRANCISCO, Jan. 25, 2012 /PRNewswire/ — WellnessFX consumer health recently extended its services to residents of Oregon in addition to California, marking the first step in an ambitious expansion plan for the San Francisco company. Access to the product was made available to California residents in early December 2010 with encouraging results. This expansion speaks not only to the building momentum behind Health 2.0, but also to WellnessFX as a pioneer in this movement. Services in the State of Washington will be available by the end of the first quarter, 2012.
WellnessFX is an online personalized wellness platform that empowers individuals to take control of their health – offering a truly integrative medical experience. Members can measure, understand, and improve their health through convenient online access, cutting edge diagnostic tools and one-on-one expert consultations with licensed health providers. Prevention is a key benefit of the WellnessFX experience. For example, the 70-plus health attributes measured in the company’s Essential Wellness panel include Inflammation Biomarkers. These are markers of chronic low-level inflammation that usually don’t produce symptoms but are now understood to be related to virtually all health problems. Markers in this panel are a critical part of assessing an individual’s risk for future diseases, including cardiovascular disease, arthritis, asthma, Alzheimer’s disease, diabetes, colitis, and more.
“More and more people are frustrated by our current medical system – inaccessible personal health data, overwhelming choice and inability to access skilled medical professionals. There is a building desire to take matters into our own hands,” says Jim Kean, chief executive officer and founder of WellnessFX. “WellnessFX provides the opportunity to do just that–detailed health markers that can detect cancer, heart disease, and other major health concerns are displayed in an accessible way and explained with the guidance of a licensed practitioner focused completely on you.”
WellnessFX has negotiated low-cost rates with its network providers and diagnostic laboratories to provide its customers online access to licensed health and wellness experts and leading diagnostic information. Prices range according to breadth of service, and the company is committed to continuing to evolve pricing options to ensure a highly customized experience and broader access to health care.
WellnessFX has an impressive lineup of Board members and advisors to help with its ambitious plans of expanding in the US, including: Mike Maples, partner at Floodgate and investor; Tim Ferriss, author and advisor; Jed Katz, managing director at Javelin Partners; Chairman of the Board, Curtis Feeney, managing director at Voyager Capital, and newly appointed Medical Director, Murdoc Khaleghi, MD and author of the ‘Everything Health’ books.
For more information, please go to: http://www.wellnessfx.com/.
WellnessFX is at the forefront of the consumer health revolution. Meeting the demand for a straightforward way to measure, track and manage one’s own health, WellnessFX creates personalized wellness roadmaps based on qualitative test results, along with customized support from leading health and wellness practitioners. With rich, personalized visualizations, WellnessFX aggregates the primary detractors of wellness, including cardiovascular disease, diabetes, metabolic syndrome and obesity, while layering in data feeds from self-tracking health and fitness devices. The result is an illuminated perspective on one’s strengths and weaknesses, which empowers individuals to make truly informed decisions about their health.
WellnessFX was started by entrepreneur Jim Kean, chief executive officer who also founded Sapient Health Network in 1995 which became the foundation of WebMD’s consumer health business. Jim partnered with Brent Vaughan, chief operations officer and co-founder of WellnessFX, in 2010 to help scale the company. Brent has over 20 years experience in the areas of diagnostics, personalized medicine, translational medicine, and pharmaceuticals that focused on bringing better predictive information empowerment closer to patients. Brent has built productive partnerships and collaborations with leading research institutions, including the National Institute of Health, National Cancer Institute and major pharmaceutical and biotechnology companies.